» Articles » PMID: 34933815

IPSCs and DRGs: Stepping Stones to New Pain Therapies

Overview
Journal Trends Mol Med
Date 2021 Dec 22
PMID 34933815
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

There is a pressing need for more effective nonaddictive treatment options for pain. Pain signals are transmitted from the periphery into the spinal cord via dorsal root ganglion (DRG) neurons, whose excitability is driven by voltage-gated sodium (Na) channels. Three Na channels (Na1.7, Na1.8, and Na1.9), preferentially expressed in DRG neurons, play important roles in pain signaling in humans. Blockade of these channels may provide a novel approach to the treatment of pain, but clinical translation of preclinical results has been challenging, in part due to differences between rodent and human DRG neurons. Human DRG neurons and iPSC-derived sensory neurons (iPSC-SNs) provide new preclinical platforms that may facilitate the development of novel pain therapeutics.

Citing Articles

Discovery of E0199: A novel compound targeting both peripheral Na and K7 channels to alleviate neuropathic pain.

Zhang B, Shi X, Liu X, Liu Y, Li X, Wang Q J Pharm Anal. 2025; 15(1):101132.

PMID: 39906690 PMC: 11791318. DOI: 10.1016/j.jpha.2024.101132.


Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings.

Asiri Y, Moni S, Ramar M, Chidambaram K Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598351 PMC: 11597627. DOI: 10.3390/ph17111439.


Light-Inducible Activation of TrkA for Probing Chronic Pain in Mice.

Liu A, Mohr M, Hope J, Wang J, Chen X, Cui B ACS Chem Biol. 2024; 19(7):1626-1637.

PMID: 39026469 PMC: 11756861. DOI: 10.1021/acschembio.4c00300.


Histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: From epigenetic to selective drugs.

Zhang W, Jiao B, Yu S, Zhang C, Zhang K, Liu B CNS Neurosci Ther. 2024; 30(5):e14745.

PMID: 38715326 PMC: 11077000. DOI: 10.1111/cns.14745.


How to differentiate induced pluripotent stem cells into sensory neurons for disease modelling: a functional assessment.

Kalia A, Rosseler C, Granja-Vazquez R, Ahmad A, Pancrazio J, Neureiter A Stem Cell Res Ther. 2024; 15(1):99.

PMID: 38581069 PMC: 10998320. DOI: 10.1186/s13287-024-03696-2.


References
1.
Liu C, Wall P, Ben-Dor E, Michaelis M, Amir R, Devor M . Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury. Pain. 2000; 85(3):503-521. DOI: 10.1016/S0304-3959(00)00251-7. View

2.
Li Y, Zhang H, Zhang H, Kosturakis A, Jawad A, Dougherty P . Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy. J Pain. 2014; 15(7):712-25. PMC: 4083500. DOI: 10.1016/j.jpain.2014.04.001. View

3.
Alsaloum M, Higerd G, Effraim P, Waxman S . Status of peripheral sodium channel blockers for non-addictive pain treatment. Nat Rev Neurol. 2020; 16(12):689-705. DOI: 10.1038/s41582-020-00415-2. View

4.
Akin E, Alsaloum M, Higerd G, Liu S, Zhao P, Dib-Hajj F . Paclitaxel increases axonal localization and vesicular trafficking of Nav1.7. Brain. 2021; 144(6):1727-1737. PMC: 8320304. DOI: 10.1093/brain/awab113. View

5.
Chambers S, Qi Y, Mica Y, Lee G, Zhang X, Niu L . Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol. 2012; 30(7):715-20. PMC: 3516136. DOI: 10.1038/nbt.2249. View